Hémorragie intracrânienne compliquant un purpura thrombopénique immunologique aigu de l'enfant : une étude rétrospective nationale

ICH is a serious and unpredictable event. Early treatment does not seem to prevent it. One should always look after suggestive clinical signs of this complication, as it requires a prompt management including immunoglobulins, steroids and platelet infusions. The use of thrombopoietin receptor agonists and other drugs still has to be defined.